top of page
Medical Checkup

TETON

Trial Enrolment Status

OPEN

Disease Under Study

Progressive Pulmonary Fibrosis

Duration

~52 Weeks

About the Trial

Evaluating the safety and efficacy of inhaled treprostinil in subjects with progressive pulmonary fibrosis (PPF) over a 52-week period.

Mechanism of Action:

​

Dr. George Philteos

Principal Investigator

Dr. George Philteos

Sub-Investigator

Dr. Anushya Chelvanathan

Study Coordinator

Cynthia Lee

bottom of page